Elsevier

Medical Hypotheses

Volume 27, Issue 4, December 1988, Pages 303-311
Medical Hypotheses

Di-iodothyronine as part of the oestradiol and catechol oestrogen receptor — The role of iodine, thyroid hormones and melatonin in the aetiology of breast cancer

https://doi.org/10.1016/0306-9877(88)90012-6Get rights and content

Abstract

Hypothyroidism and low iodine intake may be important aetiological factors in oestrogen dependent tumours of the breast, uterus and ovary. They are preventable risk factors. Iodine supplementation will hopefully lead to a decreased incidence of these cancers in future generations.

The present author proposes that the tyrosyl residue in the hydrophobic oestrogen binding site of the oestrogen receptor is post translationally modified to monoiodotyrosine and hence 3,3′ di-iodothyronine monoamine (T2) by peroxidase activity. He has previously proposed that various monoamine receptors are also T2 based. The densities of these receptors are increased in hypothyroidism and they exert control over release of prolactin and other hormones, including melatonin at multiple sites in the hypothalamic — pituitary axis. Melatonin is a metabolite of serotonin and hence melatonin receptors may be T2 or rT3 based as well. These factors could be significant in the aetiology of breast cancer as high prolactin and melatonin levels may be protective.

Oestrogen receptor density may be increased in hypothyroidism as is certain monoamine receptor density. This would amplify the effect of high circulation oestrogen levels in hypothyroidism and may help explain why hypothyroidism and low iodine intake are risk factors for breast, uterine and ovarian cancer.

References (53)

  • GL Greene et al.

    Steroid receptor structure (including monoclonal antibodies and new methods of determination). Structure and dynamics of the oestrogen receptors

    Journal of Steroid Biochemistry

    (1986)
  • BS Thomas

    Thyroid function and breast cancer

    Commentaries on Research in Breast

    (1983)
  • JGC Spencer

    The influence of the thyroid in malignant disease

    British Journal of Cancer

    (1954)
  • GM Bogardus et al.

    Breast cancer and thyroid disease

    Surgery

    (1961)
  • BO Barnes

    Thyroid supplements and breast cancer

    Journal of the American Medical Association

    (1976)
  • PK Siiteri et al.

    Increased availability of serum oestrogens in breast cancer, a new hypothesis

  • DF Horrobin

    The investigation of prostaglandin actions

  • JP Bizelikian et al.

    The influence of hyperthyroidism and hypothyroidism on alpha and beta adrenergic receptor systems and adrenergic responsiveness

    Endocrine Reviews

    (1983)
  • A Clur

    Iodothyronines and iodotyrosines as hypothetical receptors for catecholamines and opiates

    Medical Hypotheses

    (1985)
  • RA Karmali et al.

    Letter to the editor

    The Lancet

    (1978)
  • GC Prasad et al.

    Pineal, thyroid relationships in breast cancer

    Indian Journal of Cancer

    (1985)
  • IJ Chopra et al.

    Misleadingly low free thyroxine index and usefulness of reverse triiodothyronine measurements in non thyroidal illnesses

    Annals of Internal Medicine

    (1979)
  • NJ Christensen

    Increased levels of plasma noradrenaline in hypothyroidism

    Journal of Clinial Endocrinology and Metabolism

    (1972)
  • T Hamilton

    Influence of environmental light and melatonin upon mammary tumour induction

    British Journal of Surgery

    (1969)
  • KA Aldenger et al.

    Thyroid stimulation hormone and prolactin levels in breast cancer

    Archives of Lutern Medicine

    (1978)
  • H Colquhoun et al.

    Chemistry beyond the molecule

    New Scientist, London

    (May 1986)
  • Cited by (0)

    View full text